Common Stock, Shares, Outstanding of MARINUS PHARMACEUTICALS, INC. from 31 Dec 2013 to 30 Sep 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
MARINUS PHARMACEUTICALS, INC. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2013 to 30 Sep 2024.
  • MARINUS PHARMACEUTICALS, INC. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2024 was 55,185,622, a 1.1% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

MARINUS PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 55,185,622 +612,132 +1.1% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 54,963,919 +4,354,737 +8.6% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 54,931,042 +5,265,925 +11% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 54,578,121 +4,935,354 +9.9% 31 Dec 2023 10-Q 12 Nov 2024 2024 Q3
Q3 2023 54,573,490 +17,376,846 +47% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 50,609,182 +13,410,032 +36% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 49,665,117 +12,526,443 +34% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 49,642,767 +12,852,513 +35% 31 Dec 2022 10-K 05 Mar 2024 2023 FY
Q3 2022 37,196,644 +445,443 +1.2% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 37,199,150 +466,748 +1.3% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 37,138,674 +505,184 +1.4% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 36,790,254 +211,794 +0.58% 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q3 2021 36,751,201 +6,175,886 +20% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 36,732,402 -85,462,281 -70% 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 36,633,490 -50,098,545 -58% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 36,578,460 +14,960,679 +69% 31 Dec 2020 10-K 24 Mar 2022 2021 FY
Q3 2020 30,575,315 -22,003,518 -42% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 122,194,683 +69,640,058 +133% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 86,732,035 +34,177,410 +65% 31 Mar 2020 10-Q 04 May 2020 2020 Q1
Q4 2019 21,617,781 -30,901,232 -59% 31 Dec 2019 10-K 09 Mar 2021 2020 FY
Q3 2019 52,578,833 +12,053,820 +30% 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 52,554,625 +12,029,612 +30% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 52,554,625 +12,033,920 +30% 31 Mar 2019 10-Q 01 May 2019 2019 Q1
Q4 2018 52,519,013 +11,998,308 +30% 31 Dec 2018 10-K 16 Mar 2020 2019 FY
Q3 2018 40,525,013 +94,817 +0.24% 30 Sep 2018 10-Q 29 Oct 2018 2018 Q3
Q2 2018 40,525,013 +18,105,509 +81% 30 Jun 2018 10-Q 03 Aug 2018 2018 Q2
Q1 2018 40,520,705 +18,595,973 +85% 31 Mar 2018 10-Q 02 May 2018 2018 Q1
Q4 2017 40,520,705 +20,815,585 +106% 31 Dec 2017 10-K 12 Mar 2019 2018 FY
Q3 2017 40,430,196 +20,724,701 +105% 30 Sep 2017 10-Q 31 Oct 2017 2017 Q3
Q2 2017 22,419,504 +2,910,284 +15% 30 Jun 2017 10-Q 01 Aug 2017 2017 Q2
Q1 2017 21,924,732 +2,415,512 +12% 31 Mar 2017 10-Q 01 May 2017 2017 Q1
Q4 2016 19,705,120 +314,265 +1.6% 31 Dec 2016 10-K 07 Mar 2018 2017 FY
Q3 2016 19,705,495 +5,370,643 +37% 30 Sep 2016 10-Q 08 Nov 2016 2016 Q3
Q2 2016 19,509,220 +5,276,554 +37% 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 19,509,220 +5,309,554 +37% 31 Mar 2016 10-Q 02 May 2016 2016 Q1
Q4 2015 19,390,855 +5,383,101 +38% 31 Dec 2015 10-K 13 Mar 2017 2016 FY
Q3 2015 14,334,852 +422,697 +3% 30 Sep 2015 10-Q 29 Oct 2015 2015 Q3
Q2 2015 14,232,666 +13,740,602 +2792% 30 Jun 2015 10-Q 04 Aug 2015 2015 Q2
Q1 2015 14,199,666 31 Mar 2015 10-Q 14 May 2015 2015 Q1
Q4 2014 14,007,754 +13,542,725 +2912% 31 Dec 2014 10-K 07 Mar 2016 2015 FY
Q3 2014 13,912,155 30 Sep 2014 10-Q 13 Nov 2014 2014 Q3
Q2 2014 492,064 30 Jun 2014 10-Q/A 10 Oct 2014 2014 Q2
Q4 2013 465,029 31 Dec 2013 10-K 12 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.